Skip to main content
Premium Trial:

Request an Annual Quote

Changes in Enthusiasm

The fortunes of Nektar Therapeutics mirror that of the wider biotech industry, the Wall Street Journal writes.

In 2018, Nektar entered into a more than $1 billion agreement with Bristol-Myers Squibb to test whether Nektar's drug bempegaldesleukin, a modified version of interleukin-2, could increase the effectiveness of Bristol-Myers' Opdivo, a checkpoint inhibitor, the Journal says. It adds that the companies were so confident, they skipped from a phase I trial to a phase III trial — but that study failed.

According to the Journal, the companies stopped their trials and ended their deal, and Nektar's valuation fell by two thirds. It now, the Journal says, is selling its research facility in India and subleasing part of its office space in San Francisco.

Other biotech firms, it says, are also adopting similar cost-cutting strategies. For instance, it notes that Bluebird Bio is both cutting its spending and workforce while Solid Biosciences is cutting its workforce.

"The company's ups and, now, downs are an example of how investor enthusiasm for biotechnology has soured in recent months, spurred in part by a series of setbacks such as Nektar's cancer-drug failure," the Journal says.

Filed under

The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.